| Leader | | | 00000cz a2200037n 45 0 |
| 001 | | | fst01995186 |
| 003 | | | OCoLC |
| 005 | | | 20201106120917.0 |
| 008 | | | 180423n| anznnbabn || ana d |
| 016 | 7 | |
‡a fst01995186
‡2 OCoLC
|
| 024 | 7 | |
‡a http://id.worldcat.org/fast/1995186
‡2 uri
|
| 040 | | |
‡a OCoLC
‡b eng
‡c OCoLC
‡f fast
|
| 110 | 2 | |
‡a AstraZeneca (Firm)
|
| 368 | | |
‡a Business enterprises
‡2 lcsh
|
| 370 | | |
‡e Cambridge (England)
‡2 naf
|
| 372 | | |
‡a Drugs--Design
‡a Biopharmaceutics--Design
‡2 lcsh
|
| 410 | 2 | |
‡a Astra Zeneca (Firm)
|
| 410 | 2 | |
‡a AstraZeneca Pharmaceuticals
|
| 510 | 2 | |
‡w r
‡i Component of mergerr:
‡a Astra (Firm : Sweden)
‡0 (OCoLC)fst01923516
|
| 688 | | |
‡a LC (2022) Subject Usage: 1
|
| 688 | | |
‡a WC (2022) Subject Usage: 16
|
| 710 | 2 | 0 |
‡a AstraZeneca (Firm)
‡0 (DLC)no2010135192
|
| 710 | 2 | 0 |
‡a AstraZeneca (Firm)
‡0 (viaf)154100491
‡0 https://viaf.org/viaf/154100491
|
| 710 | 2 | 4 |
‡a AstraZeneca
‡0 https://en.wikipedia.org/wiki/AstraZeneca
|